tirzepatide fda approved confirms shortage is still over, gives compounders a grace period Compounded Tirzepatide: Legal & Safe

In all treated people, regardless of any gaps in their treatment, semaglutide showed a significant 29% risk reduction for heart attack, stroke and death from any cause compared with tirzepatide (over an average follow-up of 8.3 months for semaglutide and 8.6 months for tirzepatide)

Contraception Counseling : Women using oral hormonal contraceptives should use an additional non-hormonal contraceptive method for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase

Magnesium citrate is an alternative that also helps with constipation , which can be a useful secondary benefit

By 24 months, the proportion of patients with ongoing papilledema was lower in the tirzepatide group (RR 0.32, 95% CI 0.1890.542)

Not for human consumption, medical treatment, or veterinary use

Provider-led care for women Personalized to perimenopause and menopause Complete a short intake and a licensed provider will review your case and discuss your options